Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Hayesmoore, Jesse B.G.
Languages: English
Types: Doctoral thesis
In recent years, molecular genetics research has identified a large number of putative susceptibility genes for a variety of complex psychiatric and neurodegenerative disorders. However, in most instances, the particular functional variants involved have not been identified, and it is typically unclear by what mechanism the pathogenic effect is mediated. Where a genetic association does not appear to be fully explicable by variants that alter the amino acid sequence of a protein, it is a reasonable hypothesis that the association might be mediated by cis-acting variants that alter gene expression. This hypothesis was tested in this thesis in relation to 10 putative susceptibility genes for psychiatric and neurodegenerative disorders. The genes were DISCI, RELN, GABRA4, GABRA5, GABRB1, GABRB2, GABRG2, GABRG3, NOS1AP and MAPT. Each one of these genes was investigated by assays of relative allelic expression applied to a large number of post mortem human brain samples. Samples were also genotyped for relevant variants that had previously shown association with disease in order to test those variants for a putative cis-regulatory effect. Cis-regulatory variation manifested as unequal expression of each parental gene copy at the mRNA level was detected in nearly all of the genes in at least one tissue sample. However, for only two genes (RELN and MAPT) was evidence obtained that specific variants implicated in disease influenced expression.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Petryshen, T. L., Middleton, F. A., Tahl, A. R., Rockwell, G. N., Purcell, S., Aldinger, K. A., Kirby, A., Morley, C. P., McGann, L., Gentile, K. L., Waggoner, S. G., Medeiros, H. M., Carvalho, C., Macedo, A., Albus, M., Maier, W., Trixler, M., Eichhammer, P., Schwab, S. G., Wildenauer, D. B., Azevedo, M. H., Pato, M. T., Pato, C. N., Daly, M. J., & Sklar, P. (2005). Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry. 10: 1074- 1088, 1057.
    • Pilz, D. T., Matsumoto, N., Minnerath, S., Mills, P., Gleeson, J. G., Allen, K. M., Walsh, C. A., Barkovich, A. J., Dobyns, W. B., Ledbetter, D. H., & Ross, M. E. (1998). LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns o f malformation. Hum Mol Genet. 7: 2029-2037.
    • Pittman, A. M., Myers, A. J., Duckworth, J., Bryden, L., Hanson, M., Abou-Sleiman, P., Wood, N. W., Hardy, J., Lees, A., & de Silva, R. (2004). The structure o f the tau haplotype in controls and in progressive supranuclear palsy. Hum Mol Genet. 13: 1267-1274.
    • Pittman, A. M., Myers, A. J., Abou-Sleiman, P., Fung, H. C., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D., Williams, D., Kilford, L., Thomas, N., Morris, C. M., Dickson, D., Wood, N. W., Hardy, J., Lees, A. J., & de Silva, R. (2005). Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet. 42: 837-846.
    • Pittman, A. M., Fung, H. C., & de Silva, R. (2006). Untangling the tau gene association with neurodegenerative disorders. Hum Mol Genet. 15 Spec No 2: R188-195.
    • Pittman, A., Myers, A. J., Hardy, J., Wood, N. W., Lees, A., & de Silva, R. (2006). Increased MAPT expression is associated with progressive supranuclear palsy. Alzheimer's and Dementia. 2: S421.
    • Prast, H., & Philippu, A. (2001). Nitric oxide as modulator of neuronal function. Prog Neurobiol. 64: 51-68.
    • Pritchard, J. K. (2001). Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet. 69: 124-137.
    • Prokunina, L., & Alarcon-Riquelme, M. E. (2004). Regulatory SNPs in complex diseases: their identification and functional validation. Expert Rev Mol Med. 6: 1-15.
    • Puri, V., McQuillin, A., Thirumalai, S., Lawrence, J., Krasucki, R., Choudhury, K., Datta, S., Kerwin, S., Quested, D., Bass, N., Pimm, J., Lamb, G., Moorey, H., Kandasami, G., Badacsonyi, A., Kelly, K., Morgan, J., Punukollu, B., Nadeem, H., Curtis, D., & Gurling, H. M. (2006). Failure to confirm allelic association between markers at the CAPON gene locus and schizophrenia in a British sample. Biol Psychiatry. 59: 195-197.
    • Qu, M., Tang, F., Yue, W., Ruan, Y., Lu, T., Liu, Z., Zhang, H., Han, Y., Zhang, D., & Wang, F. (2007). Positive association of the Disrupted-in-Schizophrenia-1 gene (DISCI) with schizophrenia in the Chinese Han population. Am J Med Genet B Neuropsychiatr Genet. 144B: 266-270.
    • Radel, M., Vallejo, R. L., Iwata, N., Aragon, R., Long, J. C., Virkkunen, M., & Goldman, D. (2005). Haplotype-based localization of an alcohol dependence gene to the 5q34 {gamma}-aminobutyric acid type A gene cluster. Arch Gen Psychiatry. 62: 47-55.
    • Rademakers, R., Cruts, M., Dermaut, B., Sleegers, K., Rosso, S. M., Van den Broeck, M., Backhovens, H., van Swieten, J., van Duijn, C. M., & Van Broeckhoven, C. (2002). Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol Psychiatry. 7: 1064-1074.
    • Rademakers, R., Melquist, S., Cruts, M., Theuns, J., Del-Favero, J., Poorkaj, P., Baker, M., Sleegers, K., Crook, R., De Pooter, T., Bel Kacem, S., Adamson, J., Van den Bossche, D., Van den Broeck, M., Gass, J., Corsmit, E., De Rijk, P., Thomas, N., Engelborghs, S., Heckman, M., Litvan, I., Crook, J., De Deyn, P. P., Dickson, D., Schellenberg, G. D., Van Broeckhoven, C., & Hutton, M. L. (2005). High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet. 14: 3281-3292.
    • Rademakers, R., Sleegers, K., Pals, P., Nuytemans, K., Lohmann, E., Durr, A., Engelborghs, S., de Pooter, T., Van den Broeck, M., Pickut, B., Cruts, M., De Deyn, P., Farrer, M., Brice, A., & Van Broeckhoven, C. (2006). MAPT HI subhaplotyping in european PD association samples implicates tau splicing in early-onset Parkinson's disease susceptibility. Alzheimer's and Dementia. 2: S420- 421.
    • Radich, J. P., Mao, M., Stepaniants, S., Biery, M., Castle, J., Ward, T., Schimmack, G., Kobayashi, S., Carleton, M., Lampe, J., & Linsley, P. S. (2004). Individual-specific variation o f gene expression in peripheral blood leukocytes. Genomics. 83: 980- 988.
    • Reich, D. E., & Lander, E. S. (2001). On the allelic spectrum o f human disease. Trends Genet. 17: 502-510.
    • Reich, D. E., Gabriel, S. B., & Altshuler, D. (2003). Quality and completeness o f SNP databases. Nat Genet. 33: 457-458.
    • Reif, A., Herterich, S., Strobel, A., Ehlis, A. C., Saur, D., Jacob, C. P., Wienker, T., Topner, T., Fritzen, S., Walter, U., Schmitt, A., Fallgatter, A. J., & Lesch, K. P. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry. 11: 286-300.
    • Reik, W. (2007). Stability and flexibility o f epigenetic gene regulation in mammalian development. Nature. 447: 425-432.
    • Ricciarelli, R., d'Abramo, C., Massone, S., Marinari, U., Pronzato, M., Tabaton, M. (2004). Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life. 56: 349-54.
    • Rifkin, S. A., Kim, J., & White, K. P. (2003). Evolution o f gene expression in the Drosophila melanogaster subgroup. Nat Genet. 33:138-144.
    • Riley, K. P., Snowdon, D. A., & Markesbery, W. R. (2002). Alzheimer's neurofibrillary pathology and the spectrum o f cognitive function: findings from the Nun Study.
    • Rockman, M. V., & Wray, G. A. (2002). Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol. 19: 1991-2004.
    • Roks, G., Dermaut, B., Heutink, P., Julliams, A., Backhovens, H., Van de Broeck, M., Semeels, S., Hofman, A., Van Broeckhoven, C., van Duijn, C. M., & Cruts, M. (1999). Mutation screening of the tau gene in patients with early-onset Alzheimer's disease. Neurosci Lett. 277: 137-139.
    • Rosa, A., Fananas, L., Cuesta, M. J., Peralta, V., & Sham, P. (2002). Iq21-q22 locus is associated with susceptibility to the reality-distortion syndrome of schizophrenia spectrum disorders. Am J Med Genet. 114: 516-518.
    • Rozen, S., & Skaletsky, H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 132: 365-386.
    • Russ, C., Powell, J. F., Zhao, J., Baker, M., Hutton, M., Crawford, F., Mullan, M., Roks, G., Cruts, M., & Lovestone, S. (2001). The microtubule associated protein Tau gene and Alzheimer's disease-an association study and meta-analysis. Neurosci Lett. 314: 92-96.
    • Russek, S. J. (1999). Evolution of GABA(A) receptor diversity in the human genome. Gene. 227: 213-222.
    • Sachs, N. A., Sawa, A., Holmes, S. E., Ross, C. A., DeLisi, L. E., & Margolis, R. L. (2005). A ffameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry. 10: 758- 764.
    • Sasaki, S., Shionoya, A., Ishida, M., Gambello, M. J., Yingling, J., Wynshaw-Boris, A., & Hirotsune, S. (2000). A LISl/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron. 28: 681-696.
    • Sawamura, N., Sawamura-Yamamoto, T., Ozeki, Y., Ross, C. A., & Sawa, A. (2005). A form of DISCI enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proc Natl Acad Sci U S A . 102: 1187-1192.
    • Scarano, M. I., Strazzullo, M., Matarazzo, M. R., & D'Esposito, M. (2005). DNA methylation 40 years later: Its role in human health and disease. J Cell Physiol. 204: 21-35.
    • Schadt, E. E., Monks, S. A., Drake, T. A., Lusis, A. J., Che, N., Colinayo, V., Ruff, T. G., Milligan, S. B., Lamb, J. R., Cavet, G., Linsley, P. S., Mao, M., Stoughton, R. B., & Friend, S. H. (2003). Genetics of gene expression surveyed in maize, mouse and man. Nature. 422: 297-302.
    • Schadt, E. E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P. Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C., Zhu, J., Millstein, J., Sieberts, S., Lamb, J., GuhaThakurta, D., Derry, J., Storey, J. D., Avila-Campillo, I., Kruger, M. J., Johnson, J. M., Rohl, C. A., van Nas, A., Mehrabian, M., Drake, T. A., Lusis, A. J., Smith, R. C., Guengerich, F. P., Strom, S. C., Schuetz, E., Rushmore, T. H., & Ulrich, R. (2008). Mapping the genetic architecture of gene expression in human liver. PLoSBiol. 6: el07.
    • Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., Leotta, A., Pai, D., Zhang, R., Lee, Y. H., Hicks, J., Spence, S. J., Lee, A. T., Puura, K., Lehtimaki, T., Ledbetter, D., Gregersen, P. K., Bregman, J., Sutcliffe, J. S., Jobanputra, V., Chung, W., Warburton, D., King, M. C., Skuse, D., Geschwind, D. H., Gilliam, T. C., Ye, K., & Wigler, M. (2007). Strong association of de novo copy number mutations with autism. Science. 316: 445-449.
    • Serajee, F. J., Zhong, H., & Mahbubul Huq, A. H. (2006). Association of Reelin gene polymorphisms with autism. Genomics. 87: 75-83.
    • Seripa, D., Matera, M. G., D'Andrea, R. P., Gravina, C., Masullo, C., Daniele, A., Bizzarro, A., Rinaldi, M., Antuono, P., Wekstein, D. R., Dal Fomo, G., & Fazio, V. M. (2004). Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism. Neurology. 62: 1631-1633.
    • Seripa, D., Matera, M. G., Franceschi, M., Daniele, A., Bizzarro, A., Rinaldi, M., Panza, F., Fazio, V. M., Gravina, C., D'Onofrio, G., Solfrizzi, V., Masullo, C., & Pilotto, A. (2008). The RELN locus in Alzheimer's disease. JAlzheimers Dis. 14: 335-344.
    • Shahani, N., & Brandt, R. (2002). Functions and malfunctions of the tau proteins. Cell Mol LifeSci. 59: 1668-1680.
    • Shahbazian, M. D., & Grunstein, M. (2007). Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem. 76: 75-100.
    • Shao, Y., Cuccaro, M. L., Hauser, E. R., Raiford, K. L., Menold, M. M., Wolpert, C. M., Ravan, S. A., Elston, L., Decena, K., Donnelly, S. L., Abramson, R. K., Wright, H. H., DeLong, G. R., Gilbert, J. R., & Pericak-Vance, M. A. (2003). Fine mapping of autistic disorder to chromosome 15qll-ql3 by use of phenotypic subtypes. Am J Hum Genet. 72: 539-548.
    • Sharma, A., Sharma, V. K., Hom-Saban, S., Lancet, D., Ramachandran, S., & Brahmachari, S. K. (2005). Assessing natural variations in gene expression in humans by comparing with monozygotic twins using microarrays. Physiol Genomics. 21: 117-123.
    • Shaw, S. H., Kelly, M., Smith, A. B., Shields, G., Hopkins, P. J., Loftus, J., Laval, S. H., Vita, A., De Hert, M., Cardon, L. R., Crow, T. J., Sherrington, R., & DeLisi, L. E. (1998). A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet. 81: 364-376.
    • Shifman, S., Johannesson, M., Bronstein, M., Chen, S. X., Collier, D. A., Craddock, N. J., Kendler, K. S., Li, T., O'Donovan, M., O'Neill, F. A., Owen, M. J., Walsh, D., Weinberger, D. R., Sun, C., Flint, J., & Darvasi, A. (2008). Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 4: e28.
    • Shinkai, T., Ohmori, O., Hori, H., & Nakamura, J. (2002). Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry. 1: 560-563.
    • Shinoda, T., Taya, S., Tsuboi, D., Hikita, T., Matsuzawa, R., Kuroda, S., Iwamatsu, A., & Kaibuchi, K. (2007). DISCI regulates neurotrophin-induced axon elongation via interaction with Grb2. J Neurosci. 27: 4-14.
    • Sieghart, W. (1995). Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev. 47: 181-234.
    • Sieghart, W., Fuchs, K., Tretter, V., Ebert, V., Jechlinger, M., Hoger, H., & Adamiker, D. (1999). Structure and subunit composition of GABA(A) receptors. Neurochem Int. 34: 379-385.
    • Sieghart, W., & Sperk, G. (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem. 2: 795-816.
    • Sieghart, W. (2006). Structure, pharmacology, and function of GABAA receptor subtypes. Adv Pharmacol. 54: 231-263.
    • Singer-Sam, J., LeBon, J. M., Dai, A., & Riggs, A. D. (1992). A sensitive, quantitative assay for measurement o f allele-specific transcripts differing by a single nucleotide. PCR Methods Appl. 1: 160-163.
    • Sivilotti, L., & Nistri, A. (1991). GABA receptor mechanisms in the central nervous system. Prog Neurobiol. 36: 35-92.
    • Skaar, D. A., Shao, Y., Haines, J. L., Stenger, J. E., Jaworski, J., Martin, E. R., DeLong, G. R., Moore, J. H., McCauley, J. L., Sutcliffe, J. S., Ashley-Koch, A. E., Cuccaro, M. L., Folstein, S. E., Gilbert, J. R., & Pericak-Vance, M. A. (2005). Analysis o f the RELN gene as a genetic risk factor for autism. Mol Psychiatry. 10: 563-571.
    • Skipper, L., Wilkes, K., Toft, M., Baker, M., Lincoln, S., Hulihan, M., Ross, O. A., Hutton, M., Aasly, J., & Farrer, M. (2004). Linkage disequilibrium and association of MAPT HI in Parkinson disease. Am J Hum Genet. 75: 669-677.
    • Sobrido, M. J., Miller, B. L., Havlioglu, N., Zhukareva, V., Jiang, Z., Nasreddine, Z. S., Lee, V. M., Chow, T. W., Wilhelmsen, K. C., Cummings, J. L., Wu, J. Y., & Geschwind, D. H. (2003). Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch Neurol. 60: 698-702.
    • Stanford, P. M., Brooks, W. S., Teber, E. T., Hallupp, M., McLean, C., Halliday, G. M., Martins, R. N., Kwok, J. B., & Schofield, P. R. (2004). Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies. J Neurol. 251: 1098-1104.
    • Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjomsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T. T., Hjaltason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdottir, E., Bjomsson, A., Ingvarsson, B., Ingason, A., Sigfusson, S., Hardardottir, H., Harvey, R. P., Lai, D., Zhou, M., Brunner, D., Mutel, V., Gonzalo, A., Lemke, G., Sainz, J., Johannesson, G., Andresson, T., Gudbjartsson, D., Manolescu, A., Frigge, M. L., Gurney, M. E., Kong, A., Gulcher, J. R., Petursson, H., & Stefansson, K. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71: 877-892.
    • Stefansson, H., Sarginson, J., Kong, A., Yates, P., Steinthorsdottir, V., Gudfinnsson, E., Gunnarsdottir, S., Walker, N., Petursson, H., Crombie, C., Ingason, A., Gulcher, J. R., Stefansson, K., & St Clair, D. (2003). Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 72: 83-87.
    • Stefansson, H., Helgason, A., Thorleifsson, G., Steinthorsdottir, V., Masson, G., Barnard, J., Baker, A., Jonasdottir, A., Ingason, A., Gudnadottir, V. G., Desnica, N., Hicks, A., Gylfason, A., Gudbjartsson, D. F., Jonsdottir, G. M., Sainz, J., Agnarsson, K., Birgisdottir, B., Ghosh, S., Olafsdottir, A., Cazier, J. B., Kristjansson, K., Frigge, M. L., Thorgeirsson, T. E., Gulcher, J. R., Kong, A., & Stefansson, K. (2005). A common inversion under selection in Europeans. Nat Genet. 37: 129-137.
    • Stenson, P. D., Mort, M., Ball, E. V., Howells, K., Phillips, A. D., Thomas, N. S., & Cooper, D. N. (2009). The Human Gene Mutation Database: 2008 update. Genome Med. 1: 13.
    • Stephens, J. C., Schneider, J. A., Tanguay, D. A., Choi, J., Acharya, T., Stanley, S. E., Jiang, R., Messer, C. J., Chew, A., Han, J. H., Duan, J., Carr, J. L., Lee, M. S., Koshy, B., Kumar, A. M., Zhang, G., Newell, W. R., Windemuth, A., Xu, C., Kalbfleisch, T. S., Shaner, S. L., Arnold, K., Schulz, V., Drysdale, C. M., Nandabalan, K., Judson, R. S., Ruano, G., & Vovis, G. F. (2001). Haplotype variation and linkage disequilibrium in 313 human genes. Science. 293: 489-493.
    • Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A., Bird, C. P., Beazley, C., Ingle, C. E., Dunning, M., Flicek, P., Koller, D., Montgomery, S., Tavare, S., Deloukas, P., & Dermitzakis, E. T. (2007). Population genomics of human gene expression. Nat Genet. 39: 1217-1224.
    • Straub, R. E., Lipska, B. K., Egan, M. F., Goldberg, T. E., Callicott, J. H., Mayhew, M. B., Vakkalanka, R. K., Kolachana, B. S., Kleinman, J. E., & Weinberger, D. R. (2007). Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry. 12: 854-869.
    • Streffer, J. R., Papassotiropoulos, A., Kurosinski, P., Signorell, A., Wollmer, M. A., Tsolaki, M., Iakovidou, V., Homdli, F., Bosset, J., Gotz, J., Nitsch, R. M., & Hock, C. (2003). Saitohin gene is not associated with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 74: 362-363.
    • Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993a). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 90: 1977-1981.
    • Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993b). Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci US A. 90: 8098-8102.
    • Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003). Schizophrenia as a complex trait: Sunyaev, S., Ramensky, V., Koch, I., Lathe, W., 3rd, Kondrashov, A. S., & Bork, P. (2001). Prediction of deleterious human alleles. Hum Mol Genet. 10: 591-597.
    • Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992). DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1: 397-400.
    • Tamura, Y., Kunugi, H., Ohashi, J., & Hohjoh, H. (2007). Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol Psychiatry. 12: 519, 593-600.
    • Tan, Q., Christensen, K., Christiansen, L., Frederiksen, H., Bathum, L., Dahlgaard, J., & Kruse, T. A. (2005). Genetic dissection of gene expression observed in whole blood samples of elderly Danish twins. Hum Genet. 117: 267-274.
    • Tan, W., Wang, Y., Gold, B., Chen, J., Dean, M., Harrison, P. J., Weinberger, D. R., & Law, A. J. (2007). Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem. 282: 24343-24351.
    • Tang, W., Huang, K., Tang, R., Zhou, G., Fang, C., Zhang, J., Du, L., Feng, G., He, L., & Shi, Y. (2008). Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. Int J Neuropsychopharmacol. 11: 1063- 1071.
    • Taya, S., Shinoda, T., Tsuboi, D., Asaki, J., Nagai, K., Hikita, T., Kuroda, S., Kuroda, K., Shimizu, M., Hirotsune, S., Iwamatsu, A., & Kaibuchi, K. (2007). DISCI regulates the transport of the NUDEL/LISl/14-3-3epsilon complex through kinesin-1. J Tobin, J. E., Latourelle, J. C., Lew, M. F., Klein, C., Suchowersky, O., Shill, H. A., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Racette, B. A., Perlmutter, J. S., Watts, R., Guttman, M., Baker, K. B., Goldwurm, S., Pezzoli, G., Singer, C., SaintHilaire, M. H., Hendricks, A. E., Williamson, S., Nagle, M. W., Wilk, J. B., Massood, T., Laramie, J. M., DeStefano, A. L., Litvan, I., Nicholson, G., Corbett, A., Isaacson, S., Bum, D. J., Chinnery, P. F., Pramstaller, P. P., Sherman, S., Alhinti, J., Drasby, E., Nance, M., Moller, A. T., Ostergaard, K., Roxburgh, R., Snow, B., Slevin, J. T., Cambi, F., Gusella, J. F., & Myers, R. H. (2008). Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34.
    • Tochigi, M., Kato, C., Koishi, S., Kawakubo, Y., Yamamoto, K., Matsumoto, H., Hashimoto, O., Kim, S. Y., Watanabe, K., Kano, Y., Nanba, E., Kato, N., & Sasaki, T. (2007). No evidence for significant association between GABA receptor genes in chromosome 15q 11-q 13 and autism in a Japanese population. J Hum Genet. 52: 985-989.
    • Tochigi, M., Iwamoto, K., Bundo, M., Komori, A., Sasaki, T., Kato, N., & Kato, T. (2008). Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry. 63: 530-533.
    • Togo, T., Sahara, N., Yen, S. H., Cookson, N., Ishizawa, T., Hutton, M., de Silva, R., Lees, A., & Dickson, D. W. (2002). Argyrophilic grain disease is a sporadic 4-repeat Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H., & Knable, M. B. (2005). Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry. 57: 252-260.
    • Trikalinos, T. A., Karvouni, A., Zintzaras, E., Ylisaukko-oja, T., Peltonen, L., Jarvela, I., & Ioannidis, J. P. (2006). A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol Psychiatry. 11: 29-36.
    • Tsunoda, T., Lathrop, G. M., Sekine, A., Yamada, R., Takahashi, A., Ohnishi, Y., Tanaka, T., & Nakamura, Y. (2004). Variation of gene-based SNPs and linkage disequilibrium patterns in the human genome. Hum Mol Genet. 13: 1623-1632.
    • Turunen, J. A., Paunio, T., Ekelund, J., Suhonen, J., Varilo, T., Partonen, T., Jokiaho, A., Hennah, W., Parker, A., Meyer, J., Lonnqvist, J., & Peltonen, L. (2003). Association of GABRG2 gene polymorphisms with schizophrenia and visual working memory. Am J Med Genet B Neuropsychiatr Genet. 122B: 18.
    • Umeda, Y., Taniguchi, S., Arima, K., Piao, Y. S., Takahashi, H., Iwatsubo, T., Mann, D., & Hasegawa, M. (2004). Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci Lett. 359: 151-154.
    • Urak, L., Feucht, M., Fathi, N., Homik, K., & Fuchs, K. (2006). A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum Mol Genet. 15: 2533-2541.
    • Vasanthi, D., & Mishra, R. K. (2008). Epigenetic regulation of genes during development: a conserved theme from flies to mammals. J Genet Genomics. 35: 413-429.
    • Vawter, M. P., Crook, J. M., Hyde, T. M., Kleinman, J. E., Weinberger, D. R., Becker, K. G., & Freed, W. J. (2002). Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res. 58: 11-20.
    • Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S. M., Rippey, C. F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R. L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E. E., Meltzer, P. S., Nelson, S. F., Singleton, A. B., Lee, M. K., Rapoport, J. L., King, M. C., & Sebat, J. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 320: 539-543.
    • Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J. T., Abrahams, B. S., Salyakina, D., Imielinski, M., Bradfield, J. P., Sleiman, P. M., Kim, C. E., Hou, C., Frackelton, E., Chiavacci, R., Takahashi, N., Sakurai, T., Rappaport, E., Lajonchere, C. M., Munson, J., Estes, A., Korvatska, O., Piven, J., Sonnenblick, L. I., Alvarez Retuerto, A. I., Herman, E. I., Dong, H., Hutman, T., Sigman, M., Ozonoff, S., Klin, A., Owley, T., Sweeney, J. A., Brune, C. W., Cantor, R. M., Bernier, R., Gilbert, J. R., Cuccaro, M. L., McMahon, W. M., Miller, J., State, M. W., Wassink, T. H., Coon, H., Levy, S. E., Schultz, R. T., Numberger, J. I., Haines, J. L., Sutcliffe, J. S., Cook, E. H., Minshew, N. J., Buxbaum, J. D., Dawson, G., Grant, S. F., Geschwind, D. H., Pericak-Vance, M. A., Schellenberg, G. D., & Hakonarson, H. (2009). Common genetic variants on 5pl4.1 associate with autism spectrum disorders. Nature. 459: 528-533.
    • Wang, Z., Gerstein, M., & Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 10: 57-63.
    • Watanabe, A., Hasegawa, M., Suzuki, M., Takio, K., Morishima-Kawashima, M., Titani, K., Arai, T., Kosik, K. S., & Ihara, Y. (1993). In vivo phosphorylation sites in fetal and adult rat tau. J Biol Chem. 268: 25712-25717.
    • Wayne, M. L., & McIntyre, L. M. (2002). Combining mapping and arraying: An approach to candidate gene identification. Proc Natl Acad Sci U S A. 99: 14903-14906.
    • Wedenoja, J., Loukola, A., Tuulio-Henriksson, A., Paunio, T., Ekelund, J., Silander, K., Varilo, T., Heikkila, K., Suvisaari, J., Partonen, T., Lonnqvist, J., & Peltonen, L. (2008). Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry. 13: 673-684.
    • Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975). A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A . 72: 1858- 1862.
    • Williams, N. M., Preece, A., Morris, D. W., Spurlock, G., Bray, N. J., Stephens, M., Norton, N., Williams, H., Clement, M., Dwyer, S., Curran, C., Wilkinson, J., Moskvina, V., Waddington, J. L., Gill, M., Corvin, A. P., Zammit, S., Kirov, G., Owen, M. J., & O'Donovan, M. C. (2004). Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry. 61: 336-344.
    • Wong, G. K., Yang, Z., Passey, D. A., Kibukawa, M., Paddock, M., Liu, C. R., Bolund, L., & Yu, J. (2003). A population threshold for functional polymorphisms. Genome Res. 13: 1873-1879.
    • Woo, T. U., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998). A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A. 95: 5341-5346.
    • Zhang, X., Tochigi, M., Ohashi, J., Maeda, K., Kato, T., Okazaki, Y., Kato, N., Tokunaga, K., Sawa, A., & Sasaki, T. (2005b). Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophr Res. 79: 175-180.
    • Zhao, J. H., Curtis, D., & Sham, P. C. (2000). Model-free analysis and permutation tests for allelic associations. Hum Hered. 50: 133-139.
  • No similar publications.

Share - Bookmark

Funded by projects

  • WT

Cite this article